Author:
Schnöller T.J.,Zengerling F.,Hirning C.,Jentzmik F.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Babjuk M, Burger M, Zigeuner R et al (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64(4):639–653
2. Becci PJ, Thompson HJ, Grubbs CJ et al (1978) Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Cancer Res 38(12):4463–4466
3. Winter A, Vohmann C, Wawroschek F, Kieschke J (2014) Increase in uro-oncological health care needs due to demographic change: extrapolation of cancer incidence numbers through 2030 as a basis for directed regional planning. Urologe A (Epub ahead of print)
4. Vom Dorp F, Tschirdewahn S, Lummen G (2012) Intravesical therapy of non-muscle invasive bladder tumors. Urologe A 51(2):257–264
5. Delto JC, Kobayashi T, Benson M et al (2013) Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression. Oncotarget 4(2):269–276